MODULATION OF SYSTEMIC EXPOSURE TO RIFAXIMIN

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20100317681A1
SERIAL NO

12508864

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the effect of hepatic insufficiency on the pharmacokinetics of rifaximin. Also provided are methods of determining an appropriate dose of rifaximin for a subject suffering from hepatic insufficiency. In addition, methods of treatment are provided subjects having or susceptible to hepatic insufficiency to be treated with rifaximin.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SALIX PHARMACEUTICALS LTD8510 COLONNADE CENTER DRIVE RALEIGH NC 27615

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Forbes, William Raleigh, US 62 497

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation